Form 8-K - Current report:
SEC Accession No. 0001564590-19-046985
Filing Date
2019-12-27
Accepted
2019-12-26 19:35:52
Documents
1
Period of Report
2019-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K WEREWOLF AMENDMENT harp-8k_20191226.htm 8-K 29407
  Complete submission text file 0001564590-19-046985.txt   30544
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 191311588
SIC: 2836 Biological Products, (No Diagnostic Substances)